Results
|
|
1.
|
The repurposed anthelmintic mebendazole in combination with trametinib suppresses refractory NRASQ61K melanoma. MedStar authors:
- Abdussamad, Maryam
- Zapas, John
- Zhou, Hengbo
Year: 2017
Citation: - Oncotarget. 8(8):12576-12595, 2017 Feb 21
Institution: - MedStar Franklin Square Medical Center
Medline publication type:
All authors: - Abdussamad M, Atkins MB, Byers SW, Calvert V, Chen YS, Dakshanamurthy S, Fang HB, Gaur A, Petricoin EF, Rosenthal DS, Simbulan-Rosenthal CM, Zapas J, Zhou H
|
|
|
2.
|
A novel irinotecan-lipiodol nanoemulsion for intravascular administration: pharmacokinetics and biodistribution in the normal and tumor bearing rat liver. MedStar authors:
Year: 2021
Citation: - Drug Delivery. 28(1):240-251, 2021 Dec.
Institution: - MedStar Washington Hospital Center
Medline publication type:
All authors: - Avritscher R, Cortes AC, Damasco JA, Dixon K, Liang D, Liu D, Lu L, Melancon MP, Munoz NM, Swigost A, Tam AL, Tian L, Yevich S
|
|
|
3.
|
Pleckstrin homology domain-interacting protein (PHIP) as a marker and mediator of melanoma metastasis. MedStar authors:
Year: 2012
Citation: - Proceedings of the National Academy of Sciences of the United States of America. 109(18):7067-72, 2012 May 1.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Bezrookove V, Bienvenu G, Billings P, Climent J, Dar AA, De Semir D, Debs R, Federman S, Haqq C, Kashani-Sabet M, Leong SP, Meyer Tamguney TM, Miller JR 3rd, Nosrati M, Rangel J, Sagebiel RW, Thummala S, Tong S, Venna S
|
